Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Stocks Start Mostly Lower Amid Profit Taking

Tue, 31st Dec 2019 08:51

(Alliance News) - London stocks were lower on Tuesday morning, with some traders remaining away from their desks ahead of the New Year's Day holiday, while others were cashing out of a flagging Santa Rally.

The FTSE 100 index was down 43.63 points, or 0.6%, at 7,543.42 early Tuesday. The mid-cap FTSE 250 index was 33.44 points lower, or 0.2%, at 21,902.82, and the AIM All-Share index was flat at 958.11.

The retreat follows a strong Christmas week for London shares, with the FTSE 250 index of mid-caps reaching a record closing high, breaching the 22,000 mark for the first time.

The Cboe UK 100 index was down 0.6% at 12,783.36. The Cboe 250 was 0.2% lower at 19,815.78, and the Cboe Small Companies flat at 12,247.11.

The London Stock Exchange will close early at 1230 GMT for New Year's Eve. It will re-open on Thursday for a full session.

Sterling was quoted at USD1.3130 early Tuesday, flat with USD1.3136 at the London equities close on Monday.

In other currencies, the euro was trading at USD1.1205 early Tuesday, soft on USD1.1216 late Monday. Against the yen, the dollar was at JPY108.63, down slightly from JPY108.83.

In mainland Europe, the CAC 40 in Paris was down 0.4%. Financial markets in France will close early on Tuesday, while German markets are completely closed for New Year's Eve. Italy and Switzerland also are closed all day.

In Asia on Tuesday, financial markets were closed in Japan. In China, the Shanghai Composite ended up 0.3%, while the Hang Seng index in Hong Kong closed down 0.5%.

Tokyo will remain shut until Monday, while the Shanghai and Hong Kong markets are closed on New Year's Day but reopen on Thursday.

Back in London, HSBC Holdings started the day 0.6% lower after the Financial Times reported that the bank is planning to expand its exchange traded fund range in 2020 in order to revitalise its underperforming asset management business.

Nicholas Moreau, who was appointed chief executive of HSBC's asset management division in August, has devised a series of initiatives aimed at reinvigorating growth at a time when the London-listed bank is aggressively cutting costs, the FT said.

In the first half of 2020, HSBC will launch eight ETF's employing environmental, social and governance metrics to tap into rising investor demand for ESG-focused strategies.

HSBC also plans to develop a fixed income ETF platform in 2020 and to launch a range of precious metals tracker funds later in the year, the FT noted.

On AIM, Redx Pharma surged 31% in early trade to 8.68 pence. The company reported it is in "active" discussions with Samuel Waksal and associates, which could lead to a possible cash offer for the company.

In the meantime, the drug discovery and development company called on its shareholders to vote in favour of the conversion of a GBP2.5 million loan into shares. A general meeting will be held on January 21.

"We believe that this short-term funding solution will allow us time to secure the necessary longer-term funding that will enable us to advance our innovative pipeline of novel precision medicines for cancer and fibrosis," explained Chair Iain Ross.

The loan agreement was signed back in June with Moulton Goodies Ltd, Redx's largest shareholder which has over 18% stake, for a fixed rate secured loan note facility of up to GBP2.5 million. The loan is repayable in full on Tuesday. However, Moulton has requested that Redx capitalise the whole of the loan, including all unpaid interest, into new shares.

The capitalisation price pursuant to the terms of the loan notes is 5.25p per share, which will result in the issue of 52.0 million new shares to Moulton.

In the red early Tuesday was KCR Residential REIT, down 9.3%, after saying that it has been unable to publish its results for the year to the end of June until the end of 2019. The company explained that it is in the process of finalising the audit and the results will be announced "as soon as possible".

The delay is procedural having been caused by time-delays during the course of the audit which started later than expected following the closing of the corporate transaction with Torchlight Fund, the company said.

KCR Residential REIT shares will be suspended on Thursday.

Gold was quoted at USD1,524.30 early Tuesday, up from USD1,515.03 at the London equities close on Monday.

Brent oil was trading at USD66.48 early Tuesday, firm on USD66.14 at the London equities close on Monday.

The economic events calendar on Tuesday has only US data. The Johnson Redbook retail sales index is at 1355 GMT, with the monthly house price index at 1400 GMT and the US consumer confidence index at 1500 GMT.

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
9 Sep 2020 12:26

Redx signs new collaboration deal with Jazz Pharmaceuticals

(Sharecast News) - Drug discovery and development company Redx Pharma has signed a new research collaboration agreement with Jazz Pharmaceuticals to discover and develop drug candidates for two cancer targets on the Ras/Raf/MAP kinase (MAPK) pathway.

Read more
5 Aug 2020 15:11

UK EXECUTIVE CHANGE SUMMARY: InnovaDerma CEO Steps Down Immediately

UK EXECUTIVE CHANGE SUMMARY: InnovaDerma CEO Steps Down Immediately

Read more
4 Aug 2020 13:58

IN BRIEF: Redx Pharma Inks Licencing Agreement With AstraZeneca

IN BRIEF: Redx Pharma Inks Licencing Agreement With AstraZeneca

Read more
4 Aug 2020 08:45

Redx Pharma surges on AstraZeneca licensing agreement

(Sharecast News) - Redx Pharma shares soared on Tuesday after it signed a licensing agreement with AstraZeneca for its porcupine inhibitor for fibrotic diseases, RXC006.

Read more
1 Jul 2020 17:15

UK DIRECTOR DEALINGS SUMMARY: Braveheart Buys Stake In RMS From Brown

UK DIRECTOR DEALINGS SUMMARY: Braveheart Buys Stake In RMS From Brown

Read more
30 Jun 2020 14:47

IN BRIEF: Redx Pharma Plans USD30 Million Fundraise; Loss Narrows

IN BRIEF: Redx Pharma Plans USD30 Million Fundraise; Loss Narrows

Read more
18 May 2020 14:39

UK EXECUTIVE CHANGE SUMMARY: FastForward Innovations Names Chair, CEO

UK EXECUTIVE CHANGE SUMMARY: FastForward Innovations Names Chair, CEO

Read more
1 May 2020 14:36

Redmile Acquires Additional 34% Stake In Redx As Offer Closes

Redmile Acquires Additional 34% Stake In Redx As Offer Closes

Read more
23 Apr 2020 15:40

UK TRADING UPDATE SUMMARY: Braemar Says Oil Tankers Wanted For Storage

UK TRADING UPDATE SUMMARY: Braemar Says Oil Tankers Wanted For Storage

Read more
9 Apr 2020 18:38

Redmile Buys Further 24.1 Million Redx Shares, Now Holds 58% Stake

Redmile Buys Further 24.1 Million Redx Shares, Now Holds 58% Stake

Read more
2 Apr 2020 18:32

Redmile Ups Redx Pharma Stake, Buys Further 24 Million Shares

Redmile Ups Redx Pharma Stake, Buys Further 24 Million Shares

Read more
30 Mar 2020 17:04

Redx Pharma Secures GBP5 Million Loan From Redmile Group

Redx Pharma Secures GBP5 Million Loan From Redmile Group

Read more
13 Mar 2020 10:58

UK WINNERS & LOSERS SUMMARY: Premier Oil Up As It Retains Guidance

UK WINNERS & LOSERS SUMMARY: Premier Oil Up As It Retains Guidance

Read more
13 Mar 2020 10:31

Redx shares surge on possible cash offer from Yesod

(Sharecast News) - Drug discovery and development company Redx Pharma has received a further private approach from Yesod Bio-Sciences, it announced on Friday, that could lead to a possible cash offer for the entire issued and to be issued share capital of the company, at a price of 15p per share.

Read more
13 Mar 2020 09:26

Shares Soar As Redx Pharma Receives Two Acquisition Offers, Agrees One

Shares Soar As Redx Pharma Receives Two Acquisition Offers, Agrees One

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.